Corporate insider profile
Andrew Reardon Insider Trades
Andrew Reardon has reported no open-market purchases on SEC Form 4 and is a net seller of $9,820,074 across 1 company. The most recent open-market transaction was reported on Nov 2, 2026. Source: SEC Form 4 filings.
Latest reported as CLO & Secretary of LIGAND PHARMACEUTICALS INC (LGND).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$9,820,074.00
- Latest transaction
- Nov 2, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Andrew Reardon insider trading FAQ
- Is Andrew Reardon buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Andrew Reardon is a net seller of $9,820,074, with no open-market purchases reported. The latest transaction was reported on Nov 2, 2026.
- Which companies does Andrew Reardon report insider trades for?
- Andrew Reardon has reported open-market trades in LIGAND PHARMACEUTICALS INC (LGND). The latest SEC-reported relationship is CLO & Secretary of LIGAND PHARMACEUTICALS INC (LGND).
- Where does Andrew Reardon's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1950232, and refreshes this page daily.
